Back to School: How biopharma can reboot drug development. Access exclusive analysis here
ALTH was up $1.42 (61%) to $3.73 on 6.7 million shares on Thursday on news that it
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury